Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 2/3 1Phase 1 1

Status

Active not recruiting 3Recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 6

Conditions

Breast Neoplasms 2419Neoplasms 1838Carcinoma, Non-Small-Cell Lung 1591Prostatic Neoplasms 1296Colorectal Neoplasms 1117Lung Neoplasms 981Neoplasm Metastasis 828Multiple Myeloma 793Leukemia, Myeloid, Acute 773Ovarian Neoplasms 673Pancreatic Neoplasms 667Melanoma 660Squamous Cell Carcinoma of Head and Neck 589Recurrence 563Carcinoma, Hepatocellular 562Brain Neoplasms 515Glioblastoma 505Stomach Neoplasms 501Head and Neck Neoplasms 492Triple Negative Breast Neoplasms 471Lymphoma 460Uterine Cervical Neoplasms 444Carcinoma, Renal Cell 426Precursor Cell Lymphoblastic Leukemia-Lymphoma 420Lymphoma, Non-Hodgkin 387Endometrial Neoplasms 377Sarcoma 365Lymphoma, Follicular 357Urinary Bladder Neoplasms 356Lymphoma, Large B-Cell, Diffuse 355

Interventions

cemiplimab 2zimberelimab 1quemliclustat 1pembrolizumab 1lorlatinib 1fludarabine 1Interleukin-2 1Docetaxel 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Advanced Non-Small Cell Lung Cancer × 1 year × Clear all
NCT05557591 2026-05-06

A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

Regeneron Pharmaceuticals

Phase 2 Active not recruiting
51 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT07415005 2026-05-05

Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT05785767 2026-01-22

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Regeneron Pharmaceuticals

Phase 2/3 Active not recruiting
850 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT05676931 2025-10-02

EDGE-Lung

Gilead Sciences

Phase 2 Active not recruiting
400 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT07105176 2025-08-19

HS-IT101 Injection for Advanced NSCLC

Qingdao Sino-Cell Biomedicine Co., Ltd.

Phase 1 Not yet recruiting
12 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT06980272 2025-06-24

SSGJ-707 in Advanced Non-Small Cell Lung Cancer

Shenyang Sunshine Pharmaceutical Co., LTD.

Phase 3 Recruiting
420 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡